Log in to save to my catalogue

Glutaminyl cyclase inhibition attenuates pyroglutamate A[beta] and Alzheimer's disease-like patholog...

Glutaminyl cyclase inhibition attenuates pyroglutamate A[beta] and Alzheimer's disease-like patholog...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_20035737

Glutaminyl cyclase inhibition attenuates pyroglutamate A[beta] and Alzheimer's disease-like pathology

About this item

Full title

Glutaminyl cyclase inhibition attenuates pyroglutamate A[beta] and Alzheimer's disease-like pathology

Publisher

New York: Nature Publishing Group

Journal title

Nature medicine, 2008-10, Vol.14 (10), p.1106-1111

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group

More information

Scope and Contents

Contents

Because of their abundance, resistance to proteolysis, rapid aggregation and neurotoxicity, N-terminally truncated and, in particular, pyroglutamate (pE)-modified Abeta peptides have been suggested as being important in the initiation of pathological cascades resulting in the development of Alzheimer's disease. We found that the N-terminal pE-forma...

Alternative Titles

Full title

Glutaminyl cyclase inhibition attenuates pyroglutamate A[beta] and Alzheimer's disease-like pathology

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_20035737

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_20035737

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/nm.1872

How to access this item